Rudolf Prager

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka et al. · The Lancet · 2017 · 813 citations

Obesity, Metabolic Syndrome, Nutrition +8

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.

Richard N. Bergman, Rudolf Prager, Jerrold M. Olefsky · Journal of Clinical Investigation · 1987 · 777 citations · Full text

Minimal Model Approach, Euglycemic Glucose Clamp, Obesity +16

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

The Relative Benefits of Endurance and Strength Training on the Metabolic Factors and Muscle Function of People With Type 2 Diabetes Mellitus

Edmund Cauza, Ursula Hanusch‐Enserer, Barbara Strasser et al. · Archives of Physical Medicine and Rehabilitation · 2005 · 390 citations

Metabolic Syndrome, Physical Activity, Kinesiology +10

Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease

Danilo Fliser, Giovanni Pacini, R. Engelleiter et al. · Kidney International · 1998 · 355 citations · Full text

Obesity, Metabolic Syndrome, Hypertension +11